Long-Term Results of the R-CHOP Study in the Treatment of Elderly Patients with Diffuse Large B-Cell Lymphoma——A Study by the Groupe d'Etude des Lymphoma de l'Adulte
1Fisher RI, Gaynor ER, Dahlberg S, et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma [J]. N Engl J Med, 1993,328 (14) : 1002-1006.
2Cheson BD, Homing S J, Coiffier B, et al. Report of an international workshop to standardize response criteria for nonHodgkin's lymphoma [J]. J Clin Oncol, 1999,17 : 1244-1253.
3Cancer Therapy Evaluation Program. Common toxicity criteria,version 2.0.Bethesda [ M ]. MD: National Cancer Institute, March 1998.
4Coffier B, Lepage E, Briere J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma [J]. N Engl J Med, 2002,346(4) : 235-242.
5Feugier P, Van Hoof A, Seeban C, et al. Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-Cell lymphoma: A study by the Groupe d'Etude des Lymphoma de rAdulte [J]. J Clin Oncol, 2005,18(23):4117-4126.
2Davide Leopardo,Giuseppe Di Lorenzo,Amalia De Renzo,Piera Federico,Serena Luponio,Carlo Buonerba,Elide Matano,Gerardina Merola,Martina Imbimbo,Enzo Montesarchio,Antonio Rea,Maria Carmela Merola,Sabino De Placido,Giovannella Palmieri.Efficacy of rituximab in gastric diffuse large B cell lymphoma patients[J].World Journal of Gastroenterology,2010,16(20):2526-2530. 被引量：20
